Compare Intercontinental Exchange Inc. Common Stock (ICE) vs Inovio Pharmaceuticals Inc (INO) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Intercontinental Exchange Inc. Common Stock vs Inovio Pharmaceuticals Inc — how do they compare? Intercontinental Exchange Inc. Common Stock trades at $156.35 (market cap $87.21B), while Inovio Pharmaceuticals Inc trades at $1.08 (market cap $112.19M). The key difference: Intercontinental Exchange Inc. Common Stock is far larger — about 777.3× Inovio Pharmaceuticals Inc's market cap, and Intercontinental Exchange Inc. Common Stock pays a 1.34% dividend while Inovio Pharmaceuticals Inc pays none. Which is the better fit depends on your goals.
| ICE | INO | |
|---|---|---|
Market Cap | $87.21B | $112.19M |
Volume | 2,029,112 | 3,201,278 |
Sector | Financials | Health |
52-Week High | $175.10 | $2.65 |
52-Week Low | $122.91 | $0.66 |
Enterprise Value | $105.12B | $83.51M |
Dividend Yield | 1.34% | — |
Typical Hold Time | — | 43 Days |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
Inovio Pharmaceuticals trades at $1.155, up 2.21% today, with a bearish technical signal despite recent earnings beats. The company faces significant fundamental challenges with minimal revenue of $65,340 and substantial losses, reflected in a -130,000% net margin. Key catalyst is the October 30, 2026 FDA decision on INO-3107 for recurrent respiratory papillomatosis, with analyst consensus leaning bullish at a $2.75 price target.
Investment outlook hinges on FDA approval success; upside exists if INO-3107 gains approval, but persistent cash burn and lack of commercial revenue pose substantial risks. The stock remains speculative with high volatility expected around regulatory milestones.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Intercontinental Exchange Inc. Common Stock
Intercontinental Exchange provides technology and data services for financial institutions, corporations, and governments. Its businesses include exchanges and clearing, fixed-income data and analytics, and mortgage technology.
Read more on ICE →About Inovio Pharmaceuticals Inc
Inovio Pharmaceuticals Inc is a United States based biotechnology company that develops active DNA-based immunotherapies and vaccines to treat and prevent cancers and infectious diseases. The company is engaged in gene therapy, where its immunotherapy platform consists of DNA-based immunotherapy and electroporation delivery technologies.
Read more on INO →
